Sign inJoin waitlistJoin the waitlist

Mark Hunter

Director, Division of Gynecologic Oncology · University of Missouri-Columbia School of Medicine

Credentials: · · · · ·

History

University of California
2003–2006
University of California
2000–2003
David Geffen Sch of Med at UCLA
1996–2000

Research

The increasing incidence of small thyroid cancers: where are the cases coming from?
The Laryngoscope · 2010 · 146 citations
Cervical neoplasia in pregnancy. Part 1: screening and management of preinvasive disease
Review · American Journal of Obstetrics and Gynecology · 2008 · First of 3 authors · 56 citations
A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study
Gynecologic Oncology · 2015 · 54 citations

Bradley Monk
5 papers
AH
Amanda Hull
3 papers · 3 as a fellow
Krishnansu Tewari
3 papers
Sooah Ko
3 papers
CG
Carlye Goldenberg
2 papers
Erin Tuller
2 papers
KK
Kavita Krell
2 papers
Valery Rozen
2 papers · 1 as a resident
AH
Albert Hsu
1 paper
Ali Mahdavi
1 paper
Arwa Mohammad
1 paper · 1 as a resident
Brooke Barton
1 paper

Clinical trials

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2031
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Site PI · Recruiting · Phase 3
NRG Oncology
2025–2034